NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today reported that its fourth quarter 2013 revenues climbed 6 percent year over year with high- to mid-single digit growth across all three of its reporting segments.

The firm reported total revenues of $3.47 billion for the three months ended Dec. 31, compared to $3.26 billion for the fourth quarter of 2012. It beat the consensus analyst estimate of $3.31 billion for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.